Catalyst Pharmaceuticals, Inc.
CPRXDelisted Jul 15, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001369568
Catalyst Pharmaceuticals, Inc. was delisted on Jul 15, 2026; its insiders filed their last Form 4 on Jul 17, 2026; 396 institutions reported holding it in 13F filings for Q2 2026, worth $3.39B in total; Soros Fund Management was the only superinvestor holding it.
Q3 2022 vs. Q2 2022
How the institutions holding Catalyst Pharmaceuticals, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 190 | 2 | 229 | +41 |
| Shares | 75.5M | 306.4K | 85.1M | +9.94M (+13.2%) |
| Value | $531.7M | $2.15M | $1.09B | +$562.8M (+106.3%) |
2 institutions that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (65)
Institutions that held Catalyst Pharmaceuticals, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (24)
Institutions that held Catalyst Pharmaceuticals, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
Not filed for Q3 2022 yet (2)
Institutions that held Catalyst Pharmaceuticals, Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Friess Associates LLC | 305,148 | $2.14M |
| Urban Wealth Management, LLC | 1,253 | $9.00K |